Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer:

Paul Jurasz1, Scott North, Peter Venner

  • 1Department of Medical Oncology, Cross Cancer Institute and Department of Oncology, University of Alberta, Edmonton, AB, Canada T6G 2H7. Paul.K.Jurasz@uth.tmc.edu

Thrombosis Research
|March 12, 2004
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos